[go: up one dir, main page]

WO2016137266A3 - Pharmaceutical composition containing eperisone and pelubiprofen - Google Patents

Pharmaceutical composition containing eperisone and pelubiprofen Download PDF

Info

Publication number
WO2016137266A3
WO2016137266A3 PCT/KR2016/001911 KR2016001911W WO2016137266A3 WO 2016137266 A3 WO2016137266 A3 WO 2016137266A3 KR 2016001911 W KR2016001911 W KR 2016001911W WO 2016137266 A3 WO2016137266 A3 WO 2016137266A3
Authority
WO
WIPO (PCT)
Prior art keywords
pelubiprofen
pharmaceutical composition
composition containing
eperisone
containing eperisone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2016/001911
Other languages
French (fr)
Korean (ko)
Other versions
WO2016137266A2 (en
Inventor
채보람
이경민
김정률
황한준
송세현
손세일
이홍우
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAE WON PHARMACEUTICAL CO LTD
Daewoong Pharmaceutical Co Ltd
Original Assignee
DAE WON PHARMACEUTICAL CO LTD
Daewoong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DAE WON PHARMACEUTICAL CO LTD, Daewoong Pharmaceutical Co Ltd filed Critical DAE WON PHARMACEUTICAL CO LTD
Publication of WO2016137266A2 publication Critical patent/WO2016137266A2/en
Publication of WO2016137266A3 publication Critical patent/WO2016137266A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed is a pharmaceutical composition containing pelubiprofen, eperisone, and a water insoluble polymer.
PCT/KR2016/001911 2015-02-27 2016-02-26 Pharmaceutical composition containing eperisone and pelubiprofen Ceased WO2016137266A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2015-0028626 2015-02-27
KR1020150028626A KR20160105662A (en) 2015-02-27 2015-02-27 Pharmaceutical composition comprising eperison and pelubiprofen

Publications (2)

Publication Number Publication Date
WO2016137266A2 WO2016137266A2 (en) 2016-09-01
WO2016137266A3 true WO2016137266A3 (en) 2016-10-20

Family

ID=56789724

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/001911 Ceased WO2016137266A2 (en) 2015-02-27 2016-02-26 Pharmaceutical composition containing eperisone and pelubiprofen

Country Status (2)

Country Link
KR (1) KR20160105662A (en)
WO (1) WO2016137266A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101856911B1 (en) * 2017-12-13 2018-05-10 동국대학교 산학협력단 Pharmaceutical composition of sustained-release solid dispersion of pelubiprofen and method for producing the same
KR102462607B1 (en) * 2020-11-11 2022-11-03 대원제약주식회사 Pharmaceutical composition with improved stability comprising novel salt of pelubiprofen as an active ingredient

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050114921A (en) * 2004-06-02 2005-12-07 씨제이 주식회사 Controlled release pharmaceutical compositions
KR20080059409A (en) * 2005-09-30 2008-06-27 임팩스 라보라토리즈, 인코포레이티드 Pharmaceutical formulations with immediate release and / or controlled release properties
KR20090114323A (en) * 2008-04-29 2009-11-03 한올제약주식회사 Pharmaceutical preparations
KR20100053424A (en) * 2009-07-06 2010-05-20 대원제약주식회사 Pharmaceutical formulation having improved dissolution rate and stability for oral administration containing pelubiprofen
KR20140118412A (en) * 2013-03-29 2014-10-08 초당약품공업 주식회사 Slow release pharmaceutical composition having Eperisone as active ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5007790A (en) 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
CN101257894A (en) 2005-07-07 2008-09-03 法纳姆公司 Sustained release pharmaceutical compositions for highly water soluble drugs

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050114921A (en) * 2004-06-02 2005-12-07 씨제이 주식회사 Controlled release pharmaceutical compositions
KR20080059409A (en) * 2005-09-30 2008-06-27 임팩스 라보라토리즈, 인코포레이티드 Pharmaceutical formulations with immediate release and / or controlled release properties
KR20090114323A (en) * 2008-04-29 2009-11-03 한올제약주식회사 Pharmaceutical preparations
KR20100053424A (en) * 2009-07-06 2010-05-20 대원제약주식회사 Pharmaceutical formulation having improved dissolution rate and stability for oral administration containing pelubiprofen
KR20140118412A (en) * 2013-03-29 2014-10-08 초당약품공업 주식회사 Slow release pharmaceutical composition having Eperisone as active ingredient

Also Published As

Publication number Publication date
KR20160105662A (en) 2016-09-07
WO2016137266A2 (en) 2016-09-01

Similar Documents

Publication Publication Date Title
EP3191530A4 (en) Solution polymers including one or more 1,1-disubstituted alkene compounds, solution polymerization methods, and polymer compositions
CA2956871C (en) Compounds active towards bromodomains
WO2018067512A8 (en) Spirocyclic compounds
EP3119424A4 (en) Immunogenic glycopeptides, composition comprising the glycopeptides and use thereof
EP3275916A4 (en) Polymer, oxidized polymer, polymer composition, gel-type polymer composition, and use thereof
EP3190100A4 (en) Polymerizable compound, polymer, polymerizable composition, and film
EP3241852A4 (en) Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof
WO2015168225A3 (en) Alkoxy polycarbonates, bisphenol monomers and methods of making and using the same
SA518391465B1 (en) Synthetic Polymer Based Fluid Loss Pill
IL252897A0 (en) Indenyl compounds, pharmaceutical compositions, and medical uses thereof
PL3423502T3 (en) Polymer composition, its use and a surface size
EP3162835A4 (en) Monomer composition, and curable composition including same
PL3478663T3 (en) Lactam-functionalized polymer, compositions and applications thereof
HK1248571A1 (en) Peptide-polynucleotide complex for polynucleotide transfection
EP3239183A4 (en) Modified conjugated diene polymer, and polymer composition containing said polymer
EP3101037A4 (en) Modified conjugated diene-based polymer, preparation method therefor, and rubber composition containing same
EP3692094A4 (en) Aqueous polymer composition
WO2015128858A8 (en) Plasma-supplemented formulation
EP3150611A4 (en) Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and preparation method thereof
EP3214110A4 (en) Polymerization composition, polymer using polymerization composition, and polymer electrolyte membrane using polymer
EP3313912A4 (en) Water soluble polymers and polymeric adducts along with aqueous solutions thereof
WO2016137266A3 (en) Pharmaceutical composition containing eperisone and pelubiprofen
WO2016063289A3 (en) Pharmaceutical tablet compositions comprising rifaximin
EP3255065A4 (en) Modified conjugated diene-based polymer and rubber composition containing same
EP3997186A4 (en) Aqueous polymer formulation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16755916

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16755916

Country of ref document: EP

Kind code of ref document: A2